Skip to content

pipradrol

CAS 467-60-7
18

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A CNS stimulant with serious cardiovascular and psychiatric risks, entirely prohibited in cosmetic formulations under pharmaceutical regulations.

Pipradrol (CAS 467-60-7, also known as mertron; 2-(piperidin-2-yl)indane or related structure) is a central nervous system stimulant classified as a piperidine derivative with pharmacological activity similar to amphetamines. It acts as a norepinephrine-dopamine reuptake inhibitor and has been used historically as an analeptic and for ADHD treatment, though with significant side effect concerns. Under EU Regulation (EC) No 1223/2009, substances with pharmacological activity (CNS-active agents) are prohibited in cosmetic products. The compound presents serious risks including cardiovascular effects, insomnia, and addiction potential, making it wholly incompatible with cosmetic safety requirements.

Known concerns

  • CNS stimulant prohibited in cosmetics
  • Cardiovascular and psychiatric risks
  • No topical safety data
  • EU Regulation 1223/2009 Article 4 violation

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find pipradrol in your products.

Scan any cosmetic product with LuxSense to see if it contains pipradrol and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.